FERMT3 and breast cancer: In this study, we developed mAbs against phosphorylated kindlin-3 and showed that 10G5 clone specifically recognizes pS484 in different cell types, including platelets, megakaryocytic cells and BC cells, and this phosphorylation was enhanced by agonist stimulation.